Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mitsubishi HC Capital is a Japanese diversified financial services and leasing company formed in 2021 through the business integration of Mitsubishi UFJ Lease & Finance and Hitachi Capital. The company focuses on advanced asset businesses including leasing, installment sales, asset-based finance, trade finance, mobility, logistics, real estate, aviation, environment and energy, and other specialty financing activities. It also operates healthcare financing activities in some regions, but it is not a drug developer, biotech, pharma, or healthcare products company. The requested name "Mitsubishi Capital" appears to refer most closely to Mitsubishi HC Capital, which is an active public company headquartered in Tokyo. Because the requested name is imprecise and does not exactly match the company’s current official name, this should be treated as a likely but not exact entity match.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mitsubishi Capital.